These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 21472429)

  • 1. Therapy with recombinant T-cell receptor ligand reduces infarct size and infiltrating inflammatory cells in brain after middle cerebral artery occlusion in mice.
    Dziennis S; Mader S; Akiyoshi K; Ren X; Ayala P; Burrows GG; Vandenbark AA; Herson PS; Hurn PD; Offner HA
    Metab Brain Dis; 2011 Jun; 26(2):123-33. PubMed ID: 21472429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant T cell receptor ligand treats experimental stroke.
    Subramanian S; Zhang B; Kosaka Y; Burrows GG; Grafe MR; Vandenbark AA; Hurn PD; Offner H
    Stroke; 2009 Jul; 40(7):2539-45. PubMed ID: 19443805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myelin specific cells infiltrate MCAO lesions and exacerbate stroke severity.
    Ren X; Akiyoshi K; Grafe MR; Vandenbark AA; Hurn PD; Herson PS; Offner H
    Metab Brain Dis; 2012 Mar; 27(1):7-15. PubMed ID: 21989743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant TCR ligand reverses clinical signs and CNS damage of EAE induced by recombinant human MOG.
    Sinha S; Subramanian S; Emerson-Webber A; Lindner M; Burrows GG; Grafe M; Linington C; Vandenbark AA; Bernard CC; Offner H
    J Neuroimmune Pharmacol; 2010 Jun; 5(2):231-9. PubMed ID: 19789980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of experimental stroke with IL-10-producing B-cells reduces infarct size and peripheral and CNS inflammation in wild-type B-cell-sufficient mice.
    Bodhankar S; Chen Y; Vandenbark AA; Murphy SJ; Offner H
    Metab Brain Dis; 2014 Mar; 29(1):59-73. PubMed ID: 24374817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nasal vaccination with myelin oligodendrocyte glycoprotein reduces stroke size by inducing IL-10-producing CD4+ T cells.
    Frenkel D; Huang Z; Maron R; Koldzic DN; Hancock WW; Moskowitz MA; Weiner HL
    J Immunol; 2003 Dec; 171(12):6549-55. PubMed ID: 14662856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel HLA-DRα1-MOG-35-55 construct treats experimental stroke.
    Benedek G; Zhu W; Libal N; Casper A; Yu X; Meza-Romero R; Vandenbark AA; Alkayed NJ; Offner H
    Metab Brain Dis; 2014 Mar; 29(1):37-45. PubMed ID: 24122483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant T-cell receptor ligand RTL1000 limits inflammation and decreases infarct size after experimental ischemic stroke in middle-aged mice.
    Zhu W; Dotson AL; Libal NL; Lapato AS; Bodhankar S; Offner H; Alkayed NJ
    Neuroscience; 2015 Mar; 288():112-9. PubMed ID: 25556831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant T cell receptor ligands improve outcome after experimental cerebral ischemia.
    Akiyoshi K; Dziennis S; Palmateer J; Ren X; Vandenbark AA; Offner H; Herson PS; Hurn PD
    Transl Stroke Res; 2011 Sep; 2(3):404-10. PubMed ID: 21961027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel humanized recombinant T cell receptor ligands protect the female brain after experimental stroke.
    Pan J; Palmateer J; Schallert T; Hart M; Pandya A; Vandenbark AA; Offner H; Hurn PD
    Transl Stroke Res; 2014 Oct; 5(5):577-85. PubMed ID: 24838614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental stroke induces massive, rapid activation of the peripheral immune system.
    Offner H; Subramanian S; Parker SM; Afentoulis ME; Vandenbark AA; Hurn PD
    J Cereb Blood Flow Metab; 2006 May; 26(5):654-65. PubMed ID: 16121126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DRα1-MOG-35-55 Reduces Permanent Ischemic Brain Injury.
    Wang J; Ye Q; Xu J; Benedek G; Zhang H; Yang Y; Liu H; Meza-Romero R; Vandenbark AA; Offner H; Gao Y
    Transl Stroke Res; 2017 Jun; 8(3):284-293. PubMed ID: 27988839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A promising therapeutic approach for multiple sclerosis: recombinant T-cell receptor ligands modulate experimental autoimmune encephalomyelitis by reducing interleukin-17 production and inhibiting migration of encephalitogenic cells into the CNS.
    Sinha S; Subramanian S; Proctor TM; Kaler LJ; Grafe M; Dahan R; Huan J; Vandenbark AA; Burrows GG; Offner H
    J Neurosci; 2007 Nov; 27(46):12531-9. PubMed ID: 18003831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Splenic responses play an important role in remote ischemic preconditioning-mediated neuroprotection against stroke.
    Chen C; Jiang W; Liu Z; Li F; Yang J; Zhao Y; Ran Y; Meng Y; Ji X; Geng X; Du H; Hu X
    J Neuroinflammation; 2018 May; 15(1):167. PubMed ID: 29807548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T- and B-cell-deficient mice with experimental stroke have reduced lesion size and inflammation.
    Hurn PD; Subramanian S; Parker SM; Afentoulis ME; Kaler LJ; Vandenbark AA; Offner H
    J Cereb Blood Flow Metab; 2007 Nov; 27(11):1798-805. PubMed ID: 17392692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant T cell receptor ligand treatment improves neurological outcome in the presence of tissue plasminogen activator in experimental ischemic stroke.
    Zhu W; Libal NL; Casper A; Bodhankar S; Offner H; Alkayed NJ
    Transl Stroke Res; 2014 Oct; 5(5):612-7. PubMed ID: 24953050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cocaine-and amphetamine-regulated transcript modulates peripheral immunity and protects against brain injury in experimental stroke.
    Chang L; Chen Y; Li J; Liu Z; Wang Z; Chen J; Cao W; Xu Y
    Brain Behav Immun; 2011 Feb; 25(2):260-9. PubMed ID: 20869431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RTL551 treatment of EAE reduces CD226 and T-bet+ CD4 T cells in periphery and prevents infiltration of T-bet+ IL-17, IFN-γ producing T cells into CNS.
    Sinha S; Miller LM; Subramanian S; Burrows GG; Vandenbark AA; Offner H
    PLoS One; 2011; 6(7):e21868. PubMed ID: 21750737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myelin oligodendrocyte glycoprotein-specific T and B cells cooperate to induce a Devic-like disease in mice.
    Bettelli E; Baeten D; Jäger A; Sobel RA; Kuchroo VK
    J Clin Invest; 2006 Sep; 116(9):2393-402. PubMed ID: 16955141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical evaluation of recombinant T cell receptor ligand RTL1000 as a therapeutic agent in ischemic stroke.
    Zhu W; Casper A; Libal NL; Murphy SJ; Bodhankar S; Offner H; Alkayed NJ
    Transl Stroke Res; 2015 Feb; 6(1):60-8. PubMed ID: 25270354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.